With the potential for a hard-no-deal Brexit becoming closer to reality with each passing day, the question of what this means for healthcare and pharma is ever more prominent.
A dramatic veto from Northern Ireland’s Democratic Unionist Party (DUP) saw Theresa May’s hopes of clinching a ‘divorce settlement’ with the European Union collapse yesterday.